… was to describe the effects of extended therapy with anticholinergic and β-agonist therapy
on pulmonary function, the analysis focused on those patients who successfully completed the …

… Limited data are available for the efficacy of triple therapy with two long-acting bronchodilators
and an inhaled corticosteroid in chronic obstructive pulmonary disease (COPD). We …

… Our results in a well characterised population of patients with COPD concur with the … of
COPD. Moreover, the frequency of adverse events was lower in the group of patients receiving …

… for all chronic obstructive pulmonary disease (COPD) severity … multiple clinical outcomes
in COPD in comparison to short-… These recent therapeutic developments in COPD represent …

… TDI, BDP/FF/G significantly extended the time to first CID compared with BDP/FF (HR 0.61,
P<0.001). BDP/FF/G also significantly extended the time to sustained CID compared with BDP…

… extend these findings, health-outcomes were evaluated over 1 yr in chronic obstructive
pulmonary disease (COPD) patients… for chronic obstructive pulmonary disease (COPD) patients …

… groups – clinical cures among evaluable patients were 84% in both extended- and
regular-release … However, 5-day clarithromycin extended-release was better tolerated and caused …

… our COPD patients compared to the French COPD group are shown in Table 1. The patients
included … The contribution of this extended care to improving survival for the French COPD …

… The on-line supplement presents an extended and detailed version of the methodology used
… Thus this study will also inform future trials of exacerbation preventative therapies in COPD. …

… oxygen therapy in improving survival in patients with COPD … -term and short-term oxygen
therapy, as well as the various … between a patient and their pulmonologist following a COPD …